This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
R&D Systems
product type :
protein
product name :
Recombinant Human UCH-L3 Protein, CF
catalog :
E-325
quantity :
25 ug
price :
125 USD
citations: 3
Reference
Su Z, Cao J, Wu Y, Chen W, Lin X, Wu Y, et al. Deubiquitylation of hepatitis B virus X protein (HBx) by ubiquitin-specific peptidase 15 (USP15) increases HBx stability and its transactivation activity. Sci Rep. 2017;7:40246 pubmed publisher
Shukla N, Somwar R, Smith R, Ambati S, Munoz S, Merchant M, et al. Proteasome Addiction Defined in Ewing Sarcoma Is Effectively Targeted by a Novel Class of 19S Proteasome Inhibitors. Cancer Res. 2016;76:4525-34 pubmed publisher
Liang Q, Dexheimer T, Zhang P, Rosenthal A, Villamil M, You C, et al. A selective USP1-UAF1 inhibitor links deubiquitination to DNA damage responses. Nat Chem Biol. 2014;10:298-304 pubmed publisher
product information
brand :
R&D Systems, powered by Boston Biochem
master code :
E-325
SKU :
E-325-025
product name :
Recombinant Human UCH-L3 Protein, CF
description :
The Recombinant Human UCH-L3 Protein, CF from R&D Systems, powered by Boston Biochem is derived from E. coli. The Recombinant Human UCH-L3 Protein, CF has been validated for the following applications: Enzyme Activity.
target :
UCH-L3
category :
Proteins and Enzymes
unit size :
25 ug
buffer :
X mg/ml (X µM) in 50 mM HEPES pH 7.5, 100 mM NaCl, 1 mM TCEP
conjugate :
Unconjugated
main entrez gene id :
7347
purity :
>95%, by SDS-PAGE under reducing conditions and visualized by Colloidal Coomassie® Blue stain
species :
Human
theoretical molecular weight :
26 kDa
gene symbol :
UCHL3
details of functionality :
Recombinant Human UCH-L3 is a Ubiquitin-specific deconjugating enzyme. Reaction conditions will need to be optimized for each specific application. We recommend an initial Recombinant Human UCH-L3 concentration of 0.05-5 nM. Pre-incubation for 15 minutes with 10 mM DTT is recommended to achieve maximum activity.
catalog number base :
E-325
accessionNumbers :
P15374
applications :
Enzyme Activity
source :
The Recombinant Human UCH-L3 Protein, CF from R&D Systems, powered by Boston Biochem is derived from E. coli. The Recombinant Human UCH-L3 Protein, CF has been validated for the following applications: Enzyme Activity.
USD :
125 USD
alt names :
EC 3.4.19.12, ubiquitin carboxyl-terminal esterase L3 (ubiquitin thiolesterase), ubiquitin carboxyl-terminal hydrolase isozyme L3, Ubiquitin thioesterase L3, ubiquitin thiolesterase, UCHL3, UCH-L3
storage :
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -70 °C as supplied. 3 months, -70 °C under sterile conditions after opening.
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.